Low-cost, frequent COVID-19 screening of asymptomatic people could decrease infections, deaths, and be cost-effective.

New research suggests when the COVID-19 pandemic is slowing, low-cost, recurring screening of asymptomatic people — at the expense of approximately $3 or less per test every two weeks — could decrease COVID-19 infections and deaths and be cost-effective. When the pandemic is surging